Allspring Global Investments Holdings, LLC Fibrogen Inc Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$0.79 - $2.83 $16,279 - $58,317	20,607 New	20,607 $17,000
Q2 2023 Jul 18, 2023	SELL	$2.49 - $20.59 $120,403 - $995,629	-48,355 Reduced 80.95%	11,378 $30,000
Q1 2023 Apr 13, 2023	BUY	$15.95 - $25.18 $788,727 - $1.25 Million	49,450 Added 480.89%	59,733 $1.11 Million
Q4 2022 Jan 23, 2023	BUY	$13.27 - $17.73 $19,135 - $25,566	1,442 Added 16.31%	10,283 $0
Q3 2022 Oct 26, 2022	BUY	$11.4 - $14.6 $40,481 - $51,844	3,551 Added 67.13%	8,841 $115,000
Q2 2022 Jul 25, 2022	SELL	$7.94 - $12.96 $266,529 - $435,041	-33,568 Reduced 86.39%	5,290 $55,000
Q1 2022 May 02, 2022	BUY	$12.02 - $16.79 $15,085 - $21,071	1,255 Added 3.34%	38,858 $467,000
Q4 2021 Jan 28, 2022	BUY	$9.93 - $15.39 $373,397 - $578,710	37,603 New	37,603 $530,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account